LexDanaLexDanabeta
Inventor

Mark KARBARZ

Inventor
US

Overview

2→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds14%
C07KPeptides14%
C12NMicroorganisms or enzymes14%
PatentTitleYear
12,115,154Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)202411,845,966Preparation of factor Xa derivatives2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to ALEXION PHARMA INC (1)· patent assignee history
2023–2024Based in US· patent location history
2024Patents assigned to SRX CARDIO LLC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ALEXION PHARMA INC12023
SRX CARDIO LLC12024
Locations
LocationPatentsSpan
US22023–2024